Comparing Costs and Resource Utilization Between Patients With Schizophrenia Treated With Paliperidone Palmitate or Oral Atypical Antipsychotics in California Medicaid (medi-Cal)

Pesa, JWang, LYuce, HBaşer, Onur2019-02-282019-02-282019-02-282019-02-282015Pesa J, Wang L, Yuce H, Baser O. (September 10-13, 2015). Comparing costs and resource utilization between patients with schizophrenia treated with paliperidone palmitate or oral atypical antipsychotics in California Medicaid (Medi-Cal). U.S Psychiatric & Mental Health Congress. San Diego.https://hdl.handle.net/20.500.11779/853Onur Başer (MEF Author)##nofulltext##...eninfo:eu-repo/semantics/closedAccessComparing Costs and Resource Utilization Between Patients With Schizophrenia Treated With Paliperidone Palmitate or Oral Atypical Antipsychotics in California Medicaid (medi-Cal)Conference Object